Sarepta Therapeutics, Inc. (SRPT) Latest Stock News
WEBGet the latest Sarepta Therapeutics, Inc. (SRPT) stock news and headlines to help you in your trading and investing decisions.
Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote
WEBFind the latest Sarepta Therapeutics, Inc. (SRPT) stock quote, history, news and other vital information to help you with your stock trading and investing.
SRPT Stock Price | Sarepta Therapeutics Inc. Stock Quote ... - MarketWatch
WEBOct 4, 2024 · SRPT | Complete Sarepta Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Sarepta Therapeutics’ stock soars 38% after FDA expands use of its ...
WEBJun 21, 2024 · Sarepta Therapeutics Inc.’s stock soared 38% in premarket trade Friday, after the biotech said the U.S. regulator has approved an expanded indication of its treatment for the rare muscle disorder...
News & Press Releases - Sarepta Therapeutics
WEBRead news and articles from Sarepta, a global biotechnology company developing potentially life-changing precision genetic medicine.
Sarepta Therapeutics Announces U.S. FDA Acceptance of an …
WEBCAMBRIDGE, Mass., February 16, 2024 -- (BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the U.S. Food and...
Sarepta Therapeutics Inc (SRPT) Stock Price & News - Google
WEBGet the latest Sarepta Therapeutics Inc (SRPT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Sarepta Therapeutics Announces Topline Results from EMBARK, a …
WEBOct 30, 2023 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Oct. 30, 2023-- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, today announced topline results from EMBARK (Study SRP-9001-301), a global, randomized, double-blind, placebo-controlled, Phase 3 clinical study of ELEVIDYS (delandistrogene moxeparvovec-rokl...
Sarepta Therapeutics (SRPT) Stock Surges on Gene Therapy …
WEBJun 20, 2024 · A top US Food and Drug Administration official overrode reviewers to give broad approval to Sarepta Therapeutics Inc.’s gene therapy for a rare muscle disease in children, despite a lack of data ...
Sarepta stock soars 30% premarket after FDA panel backs …
WEBMay 15, 2023 · Sarepta Therapeutics Inc.’s stock SRPT soared 30% premarket Monday, after a U.S. Food and Drug Administration panel voted 8-6 in favor of accelerated approval for the company’s latest gene...
- Some results have been removed